China Pharma Holdings (CPHI) Notes Payables (2016 - 2025)
Historic Notes Payables for China Pharma Holdings (CPHI) over the last 13 years, with Q3 2025 value amounting to $1.4 million.
- China Pharma Holdings' Notes Payables rose 34807.06% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 34807.06%. This contributed to the annual value of $1.1 million for FY2024, which is 98.57% up from last year.
- As of Q3 2025, China Pharma Holdings' Notes Payables stood at $1.4 million, which was up 34807.06% from $1.4 million recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Notes Payables registered a high of $4.6 million during Q3 2022, and its lowest value of $315428.0 during Q3 2024.
- Moreover, its 5-year median value for Notes Payables was $1.3 million (2021), whereas its average is $1.7 million.
- In the last 5 years, China Pharma Holdings' Notes Payables crashed by 8444.44% in 2024 and then surged by 34807.06% in 2025.
- Over the past 5 years, China Pharma Holdings' Notes Payables (Quarter) stood at $1.2 million in 2021, then skyrocketed by 222.25% to $3.8 million in 2022, then tumbled by 70.16% to $1.1 million in 2023, then rose by 0.99% to $1.1 million in 2024, then grew by 23.44% to $1.4 million in 2025.
- Its Notes Payables stands at $1.4 million for Q3 2025, versus $1.4 million for Q2 2025 and $1.2 million for Q1 2025.